AAPL 208.1978 -0.5171% MSFT 387.475 -1.1165% NVDA 106.615 -3.9591% GOOGL 159.045 -1.7998% GOOG 160.825 -1.8462% AMZN 185.38 -1.9102% META 544.82 -0.4477% AVGO 188.44 -2.0124% LLY 865.67 -2.1333% TSLA 277.4 -2.6496% TSM 161.02 -2.4712% V 336.0 0.2476% JPM 241.245 -0.9464% UNH 416.63 -0.4801% NVO 62.33 0.4027% WMT 94.76 -0.347% LVMUY 114.46 -0.0524% XOM 107.98 -0.5434% LVMHF 572.0 -0.3484% MA 532.3622 -0.2095%
Company Overview: Graphite One Inc. (TSXV: GPH) is a U.S.-based company focused on the development of its graphite one project, which aims to establish a fully integrated supply chain for high-quality graphite. BriaCell Therapeutics Corp. (NASDAQ: BCTX) is a clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology therapies to treat various forms of cancer. The Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
Global Markets Wrap-Up
On November 27, 2024, the S&P 500 index settled at 5998.74 with a week till date gain of 0.19%; moreover, the tech-heavy NASDAQ composite advanced by ~0.30% on a WTD basis and settled at 19060.48. While, the Russell 2000 settled at 2426.19, reflecting a gain of ~0.81% on a WTD basis.
Considering the Canadian market, the benchmark S&P/TSX Venture Composite Index (TSX: ^JX) started the week on a positive note and continued the momentum. On November 28, 2024, the index closed at 607.69 with an overall week-to-date (WTD) gain of 0.25%. Industrials and technology were the leading sectors, while financials Healthcare, basic materials, consumer cyclicals, energy, and real estate were the laggards on Thursday.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
Copyright © 2024 Krish Capital Pty Ltd. All rights reserved.
US
CA
NZ
UK
AU
IND
Please wait processing your request...